Bristol Myers Squibb Unveiled its New Logo

Bristol Myers Squibb, moving with confident steps toward becoming a global leading biopharma company following the acquisition of Celgene, introduced its new logo, reflecting this transformation. The logo is a hand symbol as a universal expression of healing, and a representation of the personal touch that the company brings to its work and to every pioneering treatment.

Bristol Myers Squibb is dedicated to its mission of discovering, developing and delivering innovative medicines that help patients prevail over serious diseases. With a wider product range, the company aims to reach more patients with its collective power in the fields of immuno-oncology, oncology, hematology, immunology.